AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
VANCOMYCIN
7 registrations across 4 African markets— 7 active
Markets with VANCOMYCIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| VANKO-WM LYOPHILISATE FOR SOLUTION FOR INFUSION | 🇷🇼Rwanda | — | active | Oct 2029 |
| VANCOCIN CP 500 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| VANCOCIN CP 1 g | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| VANCOMYCIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | VENUS REMEDIES LTD | active | — |
| VANCONEX CP Injection | 🇹🇿Tanzania | VENUS REMEDIES LIMITED | active | — |
| Vanbact Lyophhilised Powder for IV Infusion | 🇹🇿Tanzania | NabiQasim industries Pvt Ltd | active | — |
| VANCOMYCIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | VENUS REMEDIES LTD | active | — |
VANCOMYCIN in Africa — Regulatory Overview
VANCOMYCIN is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Uganda, South Africa, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.